The malaria vaccine : promising progress, but not a silver bullet
Following the WHO announcement recommending a vaccine for children at risk of contracting malaria, this L’Initiative policy brief provides analysis and insight into understanding this first ever malaria vaccine (known as RTS,S).
On October 6, through a press release1 that spread quickly around the world, the World Health Organization (WHO) announced its “historic” decision to recommend a “groundbreaking” vaccine for children at-risk of malaria. This style of enthusiastic language, which is unusual for the WHO, hints at a dramatic reality. Children under five are most impacted by malaria, representing 274,000 deaths in 2019, or 67% of global malaria-related deaths2 : one child dies every two minutes from malaria, primarily in Africa.